Cargando…
A Novel Substituted Guanidine with High Activity in vitro against Rhinoviruses
THE number and diversity of the viruses which infect the upper respiratory tract, and cause the common cold, virtually preclude the control of this disease by conventional vaccines. From this, apart from symptomatic therapy, the only hope for effective treatment of this most prevalent of diseases is...
Autores principales: | BUCKNALL, R. A., SWALLOW, D. L., MOORES, H., HARRAD, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
1973
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086493/ https://www.ncbi.nlm.nih.gov/pubmed/4357165 http://dx.doi.org/10.1038/246144a0 |
Ejemplares similares
-
Anion-Controlled Synthesis of Novel Guanidine-Substituted Oxanorbornanes
por: Barešić, Luka, et al.
Publicado: (2022) -
Antigiardial Activity of Novel Guanidine Compounds
por: Stevens, Andrew J., et al.
Publicado: (2022) -
In vitro Antibacterial Activity of Isopropoxy Benzene Guanidine Against Multidrug-Resistant Enterococci
por: Zhang, Xiufeng, et al.
Publicado: (2019) -
Leishmanicidal Activity of Guanidine Derivatives against Leishmania infantum
por: Almeida, Fernanda Silva, et al.
Publicado: (2023) -
In Vitro Antiviral Activity of Sakuranetin against Human Rhinovirus 3
por: Choi, Hwa-Jung
Publicado: (2017)